Loading...
01/09 22:04
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals mixed signals. While revenue increased and long-term growth is expected, short-term challenges like reduced gross margins, increased operating expenses, and significant net losses are concerning. The Q&A highlights potential export restrictions impacting Q1 sales and unclear management responses, further contributing to uncertainty. The absence of a share repurchase program and customer concentration risk add to the negative outlook. Despite some positive aspects, such as growth in fiscal year revenue and optimism for 2025, the immediate negative factors are likely to outweigh, predicting a negative stock price reaction.
Q4 2024 Revenue $25.1 million, up from $20.4 million in Q4 2023 (23% increase) due to continued demand from data center applications and healthy demand from joint ventures.
Q4 2024 Non-GAAP Gross Margin 17.9%, down from 23.2% in Q4 2023 (5.3 percentage points decrease) primarily due to lower benefits from the recycling program and under-absorption of manufacturing overhead.
Q4 2024 GAAP Gross Margin 17.6%, down from 22.6% in Q4 2023 (5 percentage points decrease) attributed to similar reasons as non-GAAP gross margin.
Q4 2024 Non-GAAP Operating Expenses $9.9 million, up from $7.5 million in Q4 2023 (32% increase) due to increased legal and R&D expenses.
Q4 2024 GAAP Operating Expenses $10.6 million, up from $8.2 million in Q4 2023 (29% increase) driven by the same factors as non-GAAP operating expenses.
Q4 2024 Non-GAAP Operating Loss $5.4 million, compared to a loss of $2.7 million in Q4 2023 (100% increase) reflecting higher operating expenses.
Q4 2024 GAAP Operating Loss $6.2 million, compared to a loss of $3.6 million in Q4 2023 (72% increase) due to increased operating expenses.
Q4 2024 Non-GAAP Net Loss $4.3 million or $0.10 per share, compared to a loss of $2.8 million or $0.07 per share in Q4 2023 (54% increase) due to higher operating losses.
Q4 2024 GAAP Net Loss $5.1 million or $0.12 per share, compared to a loss of $3.6 million or $0.09 per share in Q4 2023 (42% increase) attributed to increased operating losses.
Cash, Cash Equivalents and Investments $33.8 million, down from $38.8 million at the end of Q3 2024 (decrease of $5 million) primarily due to noncash depreciation and stock compensation.
Fiscal Year 2024 Revenue $99.4 million, up from $75.8 million in fiscal year 2023 (31% increase) reflecting growth across all revenue categories.
Fiscal Year 2024 Non-GAAP Gross Margin 24.3%, up from 18.1% in fiscal year 2023 (6.2 percentage points increase) indicating improved operational efficiency.
Fiscal Year 2024 GAAP Gross Margin 24%, up from 17.6% in fiscal year 2023 (6.4 percentage points increase) reflecting similar improvements as non-GAAP gross margin.
Fiscal Year 2024 Non-GAAP Net Loss $8.5 million or $0.20 per diluted share, improved from a loss of $14.3 million or $0.34 per share in fiscal year 2023 (40% improvement) due to increased revenue.
Fiscal Year 2024 GAAP Net Loss $11.6 million or $0.27 per diluted share, improved from a loss of $17.9 million or $0.42 per share in fiscal year 2023 (35% improvement) attributed to higher revenue.
Joint Venture Revenue for 2024 $32 million, up 12% from the prior year, indicating growth in the raw material joint ventures.
New Products: Brought to market both 8-inch gallium arsenide and 6-inch indium phosphide substrates, enhancing development capabilities.
R&D Investment: Increased investment in low EPD gallium arsenide crystal growth for the wireless market.
Market Expansion: Significant revenue growth in cloud and data center infrastructure market and successful penetration of the wireless handset market, particularly in China.
Emerging Markets: Identified new market opportunities in passive optical networks and high-power industrial lasers.
Operational Efficiencies: Reduced inventory by over $1 million in Q4 2024, down from peak by $6.6 million.
Joint Ventures: Consolidated joint ventures generated almost $32 million in revenue, up 12% from the prior year.
Strategic Shifts: Navigating new export permit processes for indium phosphide due to trade restrictions imposed by China.
Growth Strategy: Focus on expanding market share in gallium arsenide substrates and enhancing capabilities in raw material joint ventures.
Trade Restrictions: On February 4, China imposed trade restrictions on the export of indium phosphide material, similar to previous restrictions on gallium arsenide substrates. This requires the company to undertake an export permit process, which may delay revenue by approximately $4 million to $5 million in Q1 2025.
Regulatory Challenges: Increased environmental regulations in China may pose challenges to operations and compliance.
Supply Chain Risks: The financial performance of partially owned supply chain companies could impact overall business performance.
Economic Factors: Global economic conditions, including trade tariffs and import/export restrictions, may affect market conditions and trends.
COVID-19 Impact: Ongoing risks related to COVID-19 and other contagious diseases could disrupt operations and supply chains.
Operating Losses: The company reported a non-GAAP operating loss of $5.4 million in Q4 2024, indicating ongoing financial challenges.
Customer Concentration: Top 5 customers generated approximately 36% of total revenue, indicating a risk related to customer concentration.
Revenue Growth: Fiscal year 2024 revenue was $99.4 million, a 31% increase from $75.8 million in fiscal year 2023.
Gross Margin Improvement: Non-GAAP gross margin for fiscal year 2024 was 24.3%, up from 18.1% in fiscal year 2023.
Investment in R&D: Increased R&D expenses related to low EPD gallium arsenide crystal growth for the wireless market and development of 6-inch indium phosphide.
Expansion of Product Portfolio: Launched 8-inch gallium arsenide and 6-inch indium phosphide substrates.
Joint Ventures Revenue: Consolidated joint ventures generated almost $32 million in revenue in 2024, up 12% from the prior year.
IPO Plans: Continued efforts to list subsidiary Tongmei on the STAR Market in Shanghai.
Q1 2025 Revenue Guidance: Expected revenue in the range of $18.0 million to $20.0 million.
Q1 2025 Non-GAAP Net Loss Guidance: Expected non-GAAP net loss in the range of $0.13 to $0.15 per share.
Q1 2025 GAAP Net Loss Guidance: Expected GAAP net loss in the range of $0.15 to $0.17 per share.
Share Repurchase Program: None
The earnings call indicates strong growth in indium phosphide revenue, driven by global demand, particularly outside China. Despite a non-GAAP loss, the company is optimistic about improving gross margins and expanding capacity. The backlog for indium phosphide has more than doubled, and customer interest is high due to product quality. The Q&A session revealed positive analyst sentiment and confidence in future growth. However, the company's cash position has decreased, and some management responses lacked clarity. Overall, the positive growth outlook and strong demand outweigh the financial concerns, suggesting a positive stock price reaction.
The earnings call summary shows mixed signals: improvements in gross margins and operating expenses are positive, but ongoing losses and cash depletion are concerning. The Q&A reveals potential growth in indium phosphide demand, but uncertainties in export licenses and permitting delays pose risks. The company's optimistic guidance and backlog could boost stock, but lack of clarity on license issues tempers this optimism. The absence of a market cap makes it hard to predict volatility, but overall, the sentiment is balanced, leading to a neutral stock price prediction.
The earnings call reveals significant challenges: a 15% revenue drop, negative gross margins due to yield issues, and geopolitical/export restrictions impacting operations. Despite management's optimism about resolving yield problems, their vague responses in the Q&A raise doubts. The absence of a share repurchase program and worsening financial losses further contribute to a negative outlook. Given the critical risks and lack of positive catalysts, the stock is likely to experience a strong negative reaction (>8% decline) over the next two weeks.
The earnings call reveals mixed signals. While revenue increased and long-term growth is expected, short-term challenges like reduced gross margins, increased operating expenses, and significant net losses are concerning. The Q&A highlights potential export restrictions impacting Q1 sales and unclear management responses, further contributing to uncertainty. The absence of a share repurchase program and customer concentration risk add to the negative outlook. Despite some positive aspects, such as growth in fiscal year revenue and optimism for 2025, the immediate negative factors are likely to outweigh, predicting a negative stock price reaction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
